Clinical Trials
4 trialsNCT06930651 2026-05-06
A Phase I/II Study of CAR.70-Engineered IL15-Transduced Cord Blood-Derived NK Cells With TGF-beta Receptor 2 (TGFBR2) Knock Out in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Myeloid Malignancies
M.D. Anderson Cancer Center
Phase 1/2 Recruiting
NCT06917105 2025-04-08
Exploratory Clinical Study on the Safety and Efficacy of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Myeloid Malignancies
Tongji Hospital
Phase 1/2 Not yet recruiting
NCT02958397 2019-06-25
A Clinical Research of CD33-Targeted CAR-T in Myeloid Malignancies
Southwest Hospital, China
Phase 1/2 Unknown
NCT02958384 2018-01-23
A Clinical Research of LeY-Targeted CAR-T in Myeloid Malignancies
Southwest Hospital, China
Phase 1/2 Unknown